{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:05:15Z","timestamp":1794409515345,"version":"4.9.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-04727-z","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:07:02Z","timestamp":1769231222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence, clinical characteristics, and antibiotic resistance of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital in T\u00fcrkiye (2023\u20132025)"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9937-6267","authenticated-orcid":false,"given":"Sinan","family":"Mermer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertu\u011frul","family":"\u00c7a\u011flayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"4727_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s40265-018-0902-x","volume":"78","author":"M Shirley","year":"2018","unstructured":"Shirley M, Ceftazidime-Avibactam. A review in the treatment of serious Gram-negative bacterial infections. Drugs. 2018;78:675\u201392.","journal-title":"Drugs"},{"key":"4727_CR2","unstructured":"World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) report: 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240062702. Accessed 25 July 2025."},{"issue":"3","key":"4727_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.30934\/kusbed.1163427","volume":"8","author":"S \u00d6zta\u015f","year":"2022","unstructured":"\u00d6zta\u015f S, Er DK, D\u00fcndar D. Antimicrobial resistance of various antimicrobial agents in carbapenem resistant and susceptible isolates of Klebsiella pneumoniae. KOU Sag Bil Derg. 2022;8(3):229\u201332.","journal-title":"KOU Sag Bil Derg"},{"issue":"1","key":"4727_CR4","first-page":"25","volume":"5","author":"S Baba","year":"2022","unstructured":"Baba S, Akta\u015f Z, \u00d6nc\u00fcl MO. Investigation of the susceptibility of carbapenem resistant Klebsiella pneumoniae isolates to Apramycin. J Adv Res Health Sci. 2022;5(1):25\u201331.","journal-title":"J Adv Res Health Sci"},{"issue":"2","key":"4727_CR5","first-page":"68","volume":"45","author":"H Temiz","year":"2015","unstructured":"Temiz H, \u00d6zbek E, Vural DG, \u00d6zekinci T. Evaluation of antimicrobial resistance rates of Klebsiella isolates. Turk Mikrobiyol Cem Derg. 2015;45(2):68\u201374.","journal-title":"Turk Mikrobiyol Cem Derg"},{"key":"4727_CR6","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters, version 13.0. EUCAST; 2023. https:\/\/www.eucast.org. Accessed 25 July 20252023."},{"key":"4727_CR7","doi-asserted-by":"crossref","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ.Infectious Diseases Society of America 2022 guidance on the treatment of antimicrobial-resistant Gram-negative infections. Clin Infect Dis. 2022;74(12):2116\u201347.","DOI":"10.1093\/cid\/ciab1013"},{"issue":"2","key":"4727_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5578\/mb.20229803","volume":"56","author":"T Ho\u015fbul","year":"2022","unstructured":"Ho\u015fbul T, Aydo\u011fan CN, Kaya S, Bedir O, G\u00fcmral R, Albay A. In vitro activity of ceftazidime-avibactam and colistin against carbapenem-resistant Klebsiella pneumoniae clinical isolates. Mikrobiyol Bul. 2022;56(2):218\u201329.","journal-title":"Mikrobiyol Bul"},{"key":"4727_CR9","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","volume":"17","author":"O Zarkotou","year":"2011","unstructured":"Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17:1798.","journal-title":"Clin Microbiol Infect"},{"key":"4727_CR10","doi-asserted-by":"publisher","first-page":"32665","DOI":"10.1038\/srep32665","volume":"6","author":"PF Wu","year":"2016","unstructured":"Wu PF, Chuang C, Su CF, Lin Y, Chan YJ, Wang FD, et al. High minimum inhibitory concentration of Imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae. Sci Rep. 2016;6:32665.","journal-title":"Sci Rep"},{"key":"4727_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2147\/IDR.S193638","volume":"12","author":"CH Liao","year":"2019","unstructured":"Liao CH, Lee NY, Tang HJ, Lee SSJ, Lin CF, Lu PL, et al. Antimicrobial activities of ceftazidime\u2013avibactam, ceftolozane\u2013tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan. Infect Drug Resist. 2019;12:545\u201352.","journal-title":"Infect Drug Resist"},{"issue":"8","key":"4727_CR12","doi-asserted-by":"publisher","first-page":"e01031","DOI":"10.1128\/AAC.01031-18","volume":"62","author":"F Yu","year":"2018","unstructured":"Yu F, Lv J, Niu S, Du H, Tang YW, Bonomo RA, et al. In vitro activity of ceftazidime-avibactam against carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates. Antimicrob Agents Chemother. 2018;62(8):e01031\u201318.","journal-title":"Antimicrob Agents Chemother"},{"key":"4727_CR13","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1128\/AAC.01020-07","volume":"52","author":"MJ Schwaber","year":"2008","unstructured":"Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52:1028.","journal-title":"Antimicrob Agents Chemother"},{"key":"4727_CR14","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1099\/jmm.0.038083-0","volume":"61","author":"E Ruiz","year":"2012","unstructured":"Ruiz E, Ocampo-Sosa AA, Rezusta A, Revillo MJ, Roman E, Torres C, et al. Acquisition of carbapenem resistance in multiresistant Klebsiella pneumoniae strains harbouring blaCTX-M-15, qnrS1 and aac(6\u2019)-Ib-cr genes. J Med Microbiol. 2012;61:672.","journal-title":"J Med Microbiol"},{"key":"4727_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2147\/IDR.S347343","volume":"15","author":"N Wang","year":"2022","unstructured":"Wang N, Zhan M, Liu J, Wang Y, Hou Y, Li C, et al. Prevalence of carbapenem-resistant Klebsiella pneumoniae infection in a Northern Province in china: clinical characteristics, drug resistance, and geographic distribution. Infect Drug Resist. 2022;15:569\u201379.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"4727_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/microorganisms8010037","volume":"8","author":"P Barbadoro","year":"2019","unstructured":"Barbadoro P, Dichiara A, Arsego D, Ponzio E, Savini S, Manso E, et al. Spread of carbapenem-resistant Klebsiella pneumoniae in hub and spoke connected healthcare networks: a case study from Italy. Microorganisms. 2019;8(1):37.","journal-title":"Microorganisms"},{"issue":"6","key":"4727_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/cid\/ciw805","volume":"64","author":"LJ Rojas","year":"2017","unstructured":"Rojas LJ, Salim M, Cober E, Richter SS, Perez F, Salata RA, et al. Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality. Clin Infect Dis. 2017;64(6):711\u201318.","journal-title":"Clin Infect Dis"},{"key":"4727_CR18","doi-asserted-by":"crossref","unstructured":"Malinga NZZ, Shobo CO, Molechan C, Amoako DG, Zishiri OT, Bester LA. Molecular surveillance and dissemination of Klebsiella pneumoniae on frequently encountered surfaces in South African public hospitals. Microb Drug Resist. 2021.","DOI":"10.1089\/mdr.2020.0546"},{"issue":"2","key":"4727_CR19","doi-asserted-by":"publisher","first-page":"ofad649","DOI":"10.1093\/ofid\/ofad649","volume":"11","author":"XC Lin","year":"2023","unstructured":"Lin XC, Li CL, Zhang SY, Yang XF, Jiang M. The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: a systematic review and meta-analysis. Open Forum Infect Dis. 2023;11(2):ofad649.","journal-title":"Open Forum Infect Dis"},{"key":"4727_CR20","doi-asserted-by":"publisher","first-page":"9698","DOI":"10.1038\/s41598-025-92549-w","volume":"15","author":"ASS Monteiro","year":"2025","unstructured":"Monteiro ASS, Silva MO, Galv\u00e3o VS, Bonfim AP, Araujo LG, Silva CMP, et al. High proportions of multidrug-resistant Klebsiella pneumoniae isolates in community-acquired infections, Brazil. Sci Rep. 2025;15:9698.","journal-title":"Sci Rep"},{"issue":"5\u20136","key":"4727_CR21","doi-asserted-by":"publisher","first-page":"106679","DOI":"10.1016\/j.ijantimicag.2022.106679","volume":"60","author":"YL Lee","year":"2022","unstructured":"Lee YL, Ko WC, Hsueh PR. Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime\/avibactam, meropenem\/vaborbactam, and comparators: results from the ATLAS program. Int J Antimicrob Agents. 2022;60(5\u20136):106679.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"4727_CR22","doi-asserted-by":"publisher","first-page":"ofab026","DOI":"10.1093\/ofid\/ofab026","volume":"8","author":"K Eljaaly","year":"2021","unstructured":"Eljaaly K, Bidell MR, Gandhi RG, Alshehri S, Enani MA, Al-Jedai A, et al. Colistin nephrotoxicity: meta-analysis of randomized controlled trials. Open Forum Infect Dis. 2021;8(2):ofab026.","journal-title":"Open Forum Infect Dis"},{"key":"4727_CR23","doi-asserted-by":"crossref","unstructured":"Liu C, Wu Y, Huang L, Zhang Y, Sun Q, Lu J, et al. The Rapid Emergence of Ceftazidime-Avibactam Resistance Mediated by KPC Variants in Carbapenem-Resistant Klebsiella pneumoniae in Zhejiang Province, China. Antibiotics (Basel). 2022;11(6):731.","DOI":"10.3390\/antibiotics11060731"},{"key":"4727_CR24","doi-asserted-by":"crossref","unstructured":"Pitout JDD, Peirano G, Kock MM, Strydom K-A, Matsumura Y. The global ascendance of OXA-48-type carbapenemases in Enterobacterales. Clin Microbiol Rev. 2020;33(1):e00102\u201319.","DOI":"10.1128\/CMR.00102-19"},{"issue":"4","key":"4727_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","volume":"8","author":"D van Duin","year":"2017","unstructured":"van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8(4):460\u20139.","journal-title":"Virulence"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-04727-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04727-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04727-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:38:38Z","timestamp":1770896318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-04727-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4727"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-04727-z","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was reviewed and approved by the Medical Research Ethics Committee of Izmir University of Economics, Faculty of Medicine (Decision No: E-97429853-050.04-100909). This was a retrospective study conducted using anonymized patient data. At the time of hospital admission, all patients had signed a standard institutional consent form permitting the use of their de-identified medical information for scientific research. Therefore, no additional informed consent was required for this study. The requirement for separate informed consent was formally waived by the Medical Research Ethics Committee of Izmir University of Economics, Faculty of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}